NASDAQ
Aytu BioPharma, Inc. (AYTU) has a revenue compound annual growth rate of 19.16% over 5 years and 73.94% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.